Addex Therapeutics Ltd. (ADXN)

Market Closed

15 Oct, 08:00 PM

NASDAQ (CM)

3. 02

+0.37

+13.958%

Pre Market

3. 13

+0.11 +3.6424%

3.92M Market Cap

- P/E Ratio

- Div Yield

36,186 Volume

0 Eps

$ 2.65

Previous Close

Add Transaction

Day Range

2.75 3.25

Year Range

2.56 11.97

Want to track ADXN and more in your Portfolio? 🎯

Get Started For Free

Addex Therapeutics Ltd (ADXN) Q2 2026 Earnings Call Transcript

Seekingalpha | 2 weeks ago

Addex Therapeutics Ltd (ADXN) Q1 2026 Earnings Call Transcript

Seekingalpha | 3 months ago

Addex Therapeutics Ltd (ADXN) Q4 2025 Earnings Call Transcript

Seekingalpha | 5 months ago

Short Interest in Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Expands By 137.6%

Addex Therapeutics Ltd. Sponsored ADR (NASDAQ: ADXN - Get Free Report) was the target of a large growth in short interest in February. As of February 27th, there was short interest totaling 11,951 shares, a growth of 137.6% from the February 12th total of 5,030 shares. Currently, 1.1% of the company's stock are sold short. Based

Defenseworld | 7 months ago

Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Transcript

Seekingalpha | 10 months ago

Addex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Transcript

Addex Therapeutics Ltd (NASDAQ:ADXN ) Q4 2024 Earnings Conference Call April 25, 2025 10:00 AM ET Company Participants Tim Dyer - Co-Founder, Board Director and Chief Executive Officer Mikhail Kalinichev - Head, Translational Science Conference Call Participants Peter Ehrlich - AikenSalt Raghuram Selvaraju - HC Wainwright & Co Tim Dyer Hello everyone. I would like to thank you all for attending our 2024 Full Year Financial Results Conference Call.

Seekingalpha | 1 year ago

Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript

Addex Therapeutics Ltd (NASDAQ:ADXN ) Q3 2024 Earnings Conference Call November 22, 2024 10:00 AM ET Company Participants Tim Dyer - Co-Founder, Board Director and Chief Executive Officer Mikhail Kalinichev - Head, Translational Science Conference Call Participants Operator Good day, and thank you for standing by. Welcome to the Addex Therapeutics Third Quarter 2024 Financial Results and Corporate Update Conference Call.

Seekingalpha | 1 year ago

Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year?

Here is how Addex Therapeutics Ltd. Sponsored ADR (ADXN) and Adma Biologics (ADMA) have performed compared to their sector so far this year.

Zacks | 1 year ago

What Makes Addex Therapeutics (ADXN) a New Buy Stock

Addex Therapeutics (ADXN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 2 years ago

Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript

Addex Therapeutics Ltd (NASDAQ:ADXN ) Q2 2024 Earnings Conference Call September 30, 2024 10:00 AM ET Company Participants Tim Dyer - Co-Founder, Board Director and Chief Executive Officer Misha Kalinichev - Head, Translational Science Conference Call Participants Raghuram Selvaraju - H.C. Wainwright & Co. Operator Good day, and thank you for standing by.

Seekingalpha | 2 years ago

Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year?

Here is how Addex Therapeutics Ltd. Sponsored ADR (ADXN) and Boston Scientific (BSX) have performed compared to their sector so far this year.

Zacks | 2 years ago

Crude Oil Dips; Addex Therapeutics Shares Spike Higher

U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling around 0.2% on Tuesday.

Benzinga | 2 years ago

Blog Affiliate Program Dividend Tracker About Terms Privacy Help Contact Us